Yüklüyor......
Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin
Chronic hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. In the last 5 years, treatment for HCV infection has experienced a marked development. In 2014, the use of ledipasvir/sofosbuvir with or without concomitant weight-based ribavirin was approved wit...
Kaydedildi:
| Yayımlandı: | World J Hepatol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Inc
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5295150/ https://ncbi.nlm.nih.gov/pubmed/28217253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v9.i3.161 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|